Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer stagingPhyllis A Gimotty, DuPont Guerry, Michael E Ming, et al.
Journal of Cutaneous Pathology|February 16, 2018
Histological immune response patterns in sentinel lymph nodes involved by metastatic melanoma and prognostic significanceJames Abbott, Meghan Buckley, Laura A Taylor, et al.
Molecular Oncology|November 24, 2023
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMalay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, et al.
Surgery|December 8, 2007
Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT)Giorgos Constantine Karakousis, Dale Han, Rachel Rapaport Kelz, et al.
Nature Cell Biology|October 6, 2009
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancerKiranmai Gumireddy, Anping Li, Phyllis A Gimotty, et al.
Journal of Translational Medicine|January 10, 2008
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancerDavid O Holtz, Robert T Krafty, Alisha Mohamed-Hadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
In vivo selection for metastasis promoting genes in the mouseKiranmai Gumireddy, Fangxian Sun, Andres J Klein-Szanto, et al.
Molecular Cancer Therapeutics|March 12, 2009
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine modelXinrong Ma, Kelly Norsworthy, Namita Kundu, et al.
Annals of Surgical Oncology|November 4, 2016
Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to PrognosisGiorgos Karakousis, Phyllis A Gimotty, Edmund K Bartlett, et al.
Annals of Surgical Oncology|July 5, 2019
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic TherapiesYun Song, Andrew D Tieniber, Phyllis A Gimotty, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer stagingPhyllis A Gimotty, DuPont Guerry, Michael E Ming, et al.
Journal of Cutaneous Pathology|February 16, 2018
Histological immune response patterns in sentinel lymph nodes involved by metastatic melanoma and prognostic significanceJames Abbott, Meghan Buckley, Laura A Taylor, et al.
Molecular Oncology|November 24, 2023
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMalay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, et al.
Surgery|December 8, 2007
Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT)Giorgos Constantine Karakousis, Dale Han, Rachel Rapaport Kelz, et al.
Nature Cell Biology|October 6, 2009
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancerKiranmai Gumireddy, Anping Li, Phyllis A Gimotty, et al.
Journal of Translational Medicine|January 10, 2008
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancerDavid O Holtz, Robert T Krafty, Alisha Mohamed-Hadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
In vivo selection for metastasis promoting genes in the mouseKiranmai Gumireddy, Fangxian Sun, Andres J Klein-Szanto, et al.
Molecular Cancer Therapeutics|March 12, 2009
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine modelXinrong Ma, Kelly Norsworthy, Namita Kundu, et al.
Annals of Surgical Oncology|November 4, 2016
Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to PrognosisGiorgos Karakousis, Phyllis A Gimotty, Edmund K Bartlett, et al.
Annals of Surgical Oncology|July 5, 2019
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic TherapiesYun Song, Andrew D Tieniber, Phyllis A Gimotty, et al.
Pageof 15